Viagra and Big Pharma: A Risky Opportunity ?

The legacy of Viagra and its impact on the pharmaceutical landscape presents a thorny question for investors . Initially a hugely successful drug, copycat medications have significantly eroded its market share , creating difficulties for companies connected to the original patent holder and related developments . While particular businesses might g

read more